Annual Retained Earnings
-$3.39 B
-$606.64 M-21.81%
December 31, 2023
Summary
- As of February 7, 2025, RARE annual retained earnings is -$3.39 billion, with the most recent change of -$606.64 million (-21.81%) on December 31, 2023.
- During the last 3 years, RARE annual retained earnings has fallen by -$1.77 billion (-109.17%).
- RARE annual retained earnings is now -41440.91% below its all-time high of -$8.15 million, reached on December 31, 2011.
Performance
RARE Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$3.82 B
-$133.52 M-3.62%
September 30, 2024
Summary
- As of February 7, 2025, RARE quarterly retained earnings is -$3.82 billion, with the most recent change of -$133.52 million (-3.62%) on September 30, 2024.
- Over the past year, RARE quarterly retained earnings has dropped by -$558.99 million (-17.12%).
- RARE quarterly retained earnings is now -14030.60% below its all-time high of -$27.06 million, reached on December 31, 2012.
Performance
RARE Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
RARE Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -21.8% | -17.1% |
| 3 y3 years | -109.2% | -96.0% |
| 5 y5 years | -228.8% | -185.5% |
RARE Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -63.4% | at low | -84.4% | at low |
| 5 y | 5-year | -136.4% | at low | -166.8% | at low |
| alltime | all time | <-9999.0% | at low | <-9999.0% | at low |
Ultragenyx Pharmaceutical Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -$3.82 B(+3.6%) |
| Jun 2024 | - | -$3.69 B(+3.7%) |
| Mar 2024 | - | -$3.56 B(+5.0%) |
| Dec 2023 | -$3.39 B(+21.8%) | -$3.39 B(+3.8%) |
| Sep 2023 | - | -$3.26 B(+5.1%) |
| Jun 2023 | - | -$3.10 B(+5.4%) |
| Mar 2023 | - | -$2.94 B(+5.9%) |
| Dec 2022 | -$2.78 B(+34.1%) | -$2.78 B(+5.8%) |
| Sep 2022 | - | -$2.63 B(+10.3%) |
| Jun 2022 | - | -$2.38 B(+7.1%) |
| Mar 2022 | - | -$2.23 B(+7.3%) |
| Dec 2021 | -$2.07 B(+28.0%) | -$2.07 B(+6.3%) |
| Sep 2021 | - | -$1.95 B(+3.9%) |
| Jun 2021 | - | -$1.88 B(+7.0%) |
| Mar 2021 | - | -$1.76 B(+8.4%) |
| Dec 2020 | -$1.62 B(+13.0%) | -$1.62 B(+1.5%) |
| Sep 2020 | - | -$1.60 B(+4.5%) |
| Jun 2020 | - | -$1.53 B(-1.6%) |
| Mar 2020 | - | -$1.55 B(+8.3%) |
| Dec 2019 | -$1.43 B(+39.1%) | -$1.43 B(+7.0%) |
| Sep 2019 | - | -$1.34 B(+9.2%) |
| Jun 2019 | - | -$1.23 B(+8.8%) |
| Mar 2019 | - | -$1.13 B(+9.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2018 | -$1.03 B(+23.7%) | -$1.03 B(+9.3%) |
| Sep 2018 | - | -$942.46 M(+10.2%) |
| Jun 2018 | - | -$855.15 M(+6.6%) |
| Mar 2018 | - | -$802.42 M(-3.6%) |
| Dec 2017 | -$832.67 M(+57.0%) | -$832.67 M(+10.9%) |
| Sep 2017 | - | -$750.94 M(+11.8%) |
| Jun 2017 | - | -$671.71 M(+12.2%) |
| Mar 2017 | - | -$598.82 M(+12.9%) |
| Dec 2016 | -$530.53 M(+86.4%) | -$530.53 M(+15.5%) |
| Sep 2016 | - | -$459.25 M(+16.5%) |
| Jun 2016 | - | -$394.34 M(+16.9%) |
| Mar 2016 | - | -$337.42 M(+18.5%) |
| Dec 2015 | -$284.66 M(+104.7%) | -$284.66 M(+24.1%) |
| Sep 2015 | - | -$229.44 M(+20.6%) |
| Jun 2015 | - | -$190.21 M(+18.6%) |
| Mar 2015 | - | -$160.42 M(+15.4%) |
| Dec 2014 | -$139.04 M(+85.8%) | -$139.04 M(+13.7%) |
| Sep 2014 | - | -$122.30 M(+14.9%) |
| Jun 2014 | - | -$106.45 M(+14.6%) |
| Mar 2014 | - | -$92.87 M(+24.1%) |
| Dec 2013 | -$74.84 M(+176.6%) | -$74.84 M(+31.6%) |
| Sep 2013 | - | -$56.85 M(+110.1%) |
| Dec 2012 | -$27.06 M(+231.8%) | -$27.06 M |
| Dec 2011 | -$8.15 M | - |
FAQ
- What is Ultragenyx Pharmaceutical annual retained earnings?
- What is the all time high annual retained earnings for Ultragenyx Pharmaceutical?
- What is Ultragenyx Pharmaceutical annual retained earnings year-on-year change?
- What is Ultragenyx Pharmaceutical quarterly retained earnings?
- What is the all time high quarterly retained earnings for Ultragenyx Pharmaceutical?
- What is Ultragenyx Pharmaceutical quarterly retained earnings year-on-year change?
What is Ultragenyx Pharmaceutical annual retained earnings?
The current annual retained earnings of RARE is -$3.39 B
What is the all time high annual retained earnings for Ultragenyx Pharmaceutical?
Ultragenyx Pharmaceutical all-time high annual retained earnings is -$8.15 M
What is Ultragenyx Pharmaceutical annual retained earnings year-on-year change?
Over the past year, RARE annual retained earnings has changed by -$606.64 M (-21.81%)
What is Ultragenyx Pharmaceutical quarterly retained earnings?
The current quarterly retained earnings of RARE is -$3.82 B
What is the all time high quarterly retained earnings for Ultragenyx Pharmaceutical?
Ultragenyx Pharmaceutical all-time high quarterly retained earnings is -$27.06 M
What is Ultragenyx Pharmaceutical quarterly retained earnings year-on-year change?
Over the past year, RARE quarterly retained earnings has changed by -$558.99 M (-17.12%)